Immediate Impact
1 by Nobel laureates 2 from Science/Nature 70 standout
Citing Papers
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Towards targeting the breast cancer immune microenvironment
2024 Standout
Works of Yu Ding being referenced
LBA21 KEYNOTE-756: Phase III study of neoadjuvant pembrolizumab (pembro) or placebo (pbo) + chemotherapy (chemo), followed by adjuvant pembro or pbo + endocrine therapy (ET) for early-stage high-risk ER+/HER2– breast cancer
2023
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yu Ding | 636 | 250 | 73 | 267 | 30 | 1.1k | |
| Shanzhi Gu | 421 | 165 | 129 | 176 | 55 | 1.1k | |
| Federica Liotti | 368 | 138 | 61 | 488 | 41 | 1.2k | |
| Longsheng Hong | 300 | 135 | 130 | 142 | 21 | 955 | |
| Seunghee Kang | 427 | 133 | 100 | 207 | 26 | 1.1k | |
| Lei Li | 255 | 274 | 76 | 214 | 47 | 1.2k | |
| Jamal Hill | 512 | 135 | 32 | 162 | 32 | 1.1k | |
| Mingfang Ao | 490 | 163 | 82 | 184 | 26 | 1.2k | |
| Mei Liang | 314 | 138 | 63 | 271 | 38 | 1.0k | |
| Pei‐Li Yao | 374 | 93 | 75 | 420 | 32 | 1.4k | |
| Huan Xu | 317 | 234 | 80 | 180 | 56 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...